Shionogi & Co. Ltd. (4507.TO) Osaka Nine Months Ended December 31 GROUP 2025 2024 Revenue Y360.68 bln Y333.60 bln Operating Profit Y148.74 bln Y129.22 bln Pretax Profit Y191.27 bln Y155.88 bln Net ...
Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain ...
Dealbreaker on MSN
Pfizer pockets $1.9B by offloading stake in HIV drugs company majority owned by GSK
Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.
Pfizer in December had warned that the next few years would be bumpy, beginning with 2026, due to lower sales of its COVID ...
GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding: London, UK Wednesday, January 21, 2026, 09:00 Hrs [IST] GSK plc (GSK), and Shionogi & Co., Ltd (Shionogi ...
In today’s Pharmaceutical Executive Daily, GSK moves to strengthen its immunology pipeline with a $2 billion acquisition of ...
As a result of the acquisition, Pfizer will no longer hold shares of ViiV Healthcare Limited and Shionogi will see its holdings increase to 21.7%. 1 The majority shareholder of ViiV Healthcare Limited ...
Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.
The 11.7% economic interest in specialist HIV company ViiV Healthcare that is currently held by US pharma giant Pfizer is to ...
The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...
Pfizer will relinquish its stake in ViiV Healthcare in a deal valued at just over $2.1 billion that ramps up Shionogi's ...
GSK and Shionogi have agreed with Pfizer to restructure ViiV Healthcare’s shareholder base, with Shionogi replacing Pfizer’s 11.7 percent economic interest and increasing its stake to 21.7 percent, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results